最新发布
Insetos ampliam arsenal bioquímico contra defesas das plantas
Foto: Syngenta Insetos herbívoros utilizam diferentes sistemas de detoxificação para consumir plantas ricas em metabólit…
久易股份拟终止深交所创业板IPO
2026年9月9日，安徽久易农业股份有限公司（简称“久易股份”）发布公告称，基于公司自身业务发展方向及战略规划考虑，并经审慎研究当前我国资本市场的市…
山东省第十批制造业单项冠军企业拟认定名单公示
根据《关于加快培育发展制造业优质企业的实施意见》和《关于开展2026年山东省制造业单项冠军企业遴选和复核评价工作的通知》，经企业自愿申报，各市工业和信息化局初审推荐，经限定…
Why Africa could become India’s next agricultural sourcing frontier
What if Africa’s biggest agricultural opportunity is not producing more — but becoming more predictable? As …
Indonesia takes lobster farming from trial to export
Indonesia is moving to scale up lobster aquaculture after a farming trial in Batam produced market-sized lobsters that w…
Hokkaido becomes Japan’s launchpad for AI-powered agriculture
Japan is turning one of its biggest farming regions into a test bed for the next generation of agricultural automation, …
CloudScope Enables Continuous Remote Monitoring of Brain Activity in Freely Moving Mice
In order to understand and characterize preclinical models of diseases of the central nervous system (CNS), it is critical to be able to conduct continuous neuroimaging of multiple physiological variables—neuronal activity, blood flow, blood volume, oxygenation, and cellular dynamics—within the CNS microenvironment. This continuous multimodality neuroimaging capability is known as neurosurveillance.
Transcenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB Technology
Transcenta Therapeutics says it will grant WuXi Biologics and its affiliates a non-exclusive license to certain technologies relating to Transcenta’s intensified continuous bioprocessing (HiCB) platform and ExcelPro cell culture media.
Samsung Biologics Signs $262 Million Manufacturing Agreement with European Pharma Firm
Samsung Biologics reported that it has inked a $262 million manufacturing agreement with an unnamed European pharmaceutical company. The deal includes manufacturing commitments, which will be conducted at Samsung Biologics’ Songdo manufacturing site in South Korea extending through 2033.
Cancer Treatment Genetic Effects in Healthy Cells May Reveal Clues to Side Effects and Resistance
The results of a study by scientists at Wellcome Sanger Institute, University of Cambridge, University College London, and collaborators indicate that cancer treatments, including chemotherapy and radiotherapy, give a growth advantage to cells with particular genetic changes in healthy tissue. The team used DNA sequencing to map mutations in normal esophagus tissue from esophageal cancer patients who had received either chemotherapy, chemotherapy and radiotherapy, or no treatment before surgery.